|
81 |
Belimumab
Enthalten in Drugs in R & D Bd. 10, 27.11.2012, Nr. 1, date:5.2010: 55-65
|
|
|
|
82 |
Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy
Enthalten in CNS drugs Bd. 26, 29.8.2012, Nr. 4, date:4.2012: 319-335
|
|
|
|
83 |
Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children
Enthalten in Clinical drug investigation Bd. 32, 28.8.2012, Nr. 5, date:5.2012: 303-317
|
|
|
|
84 |
Bevacizumab for Metastatic Colorectal Cancer
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1119-1132
|
|
|
|
85 |
Bevacizumab plus Interferon-α versus Sunitinib for First-Line Treatment of Renal Cell Carcinoma in Italy
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 7, date:7.2011: 507-517
|
|
|
|
86 |
Bilastine
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 9, date:9.2012: 1257-1269
|
|
|
|
87 |
Boceprevir
Enthalten in Drugs in R & D Bd. 10, 27.11.2012, Nr. 3, date:9.2010: 203-210
|
|
|
|
88 |
Bone Physiology, Disease and Treatment
Enthalten in Clinical pharmacokinetics Bd. 49, 13.9.2012, Nr. 2, date:2.2010: 89-118
|
|
|
|
89 |
Bosentan
Enthalten in Pediatric drugs Bd. 12, 22.8.2012, Nr. 1, date:2.2010: 63-73
|
|
|
|
90 |
Bovine Colostrum Supplementation and Exercise Performance
Enthalten in Sports medicine Bd. 39, 1.12.2009, Nr. 12, date:12.2009: 1033-1054
|
|
Administration
